Labcorp Holdings Inc. (LH)
NYSE·Healthcare·Medical - Diagnostics & Research
$259.98
-1.31%
Mkt Cap $22.53B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 17, 2026 | $3.56B | $3.52B | -1.20% | $3.95 | $4.07 | +3.04% | — | — |
| Q4 2025 Oct 28, 2025 | $3.56B | $3.56B | +0.16% | $4.13 | $4.18 | +1.21% | — | — |
| Q3 2025 Jul 24, 2025 | $3.49B | $3.53B | +1.18% | $4.17 | $4.35 | +4.32% | — | — |
| Q2 2025 Apr 29, 2025 | $3.40B | $3.35B | -1.59% | $3.74 | $3.84 | +2.67% | — | — |
| Q1 2025 Feb 6, 2025 | $3.31B | $3.33B | +0.66% | $3.39 | $3.45 | +1.77% | — | — |
| Q4 2024 Oct 24, 2024 | $3.26B | $3.28B | +0.65% | $3.47 | $3.50 | +0.86% | — | — |
| Q3 2024 Aug 1, 2024 | $3.19B | $3.22B | +1.11% | $3.78 | $3.94 | +4.23% | — | — |
| Q2 2024 Apr 25, 2024 | $3.12B | $3.18B | +1.88% | $3.48 | $3.68 | +5.75% | — | — |
| Q1 2024 Feb 15, 2024 | $3.02B | $3.03B | +0.53% | $3.29 | $3.30 | +0.30% | — | — |
| Q4 2023 Oct 26, 2023 | $2.99B | $3.06B | +2.20% | $3.37 | $3.38 | +0.30% | — | — |
| Q3 2023 Jul 27, 2023 | $3.15B | $3.03B | -3.80% | $3.47 | $3.42 | -1.44% | — | — |
| Q2 2023 Apr 25, 2023 | $3.69B | $3.78B | +2.32% | $3.99 | $3.82 | -4.26% | — | — |
| Q1 2023 Feb 16, 2023 | $3.74B | $3.67B | -1.79% | $4.06 | $4.14 | +1.97% | — | — |
| Q4 2022 Oct 27, 2022 | $3.79B | $3.61B | -4.76% | $4.67 | $4.68 | +0.21% | — | — |
| Q3 2022 Jul 28, 2022 | $3.75B | $3.70B | -1.47% | $4.70 | $4.95 | +5.32% | — | — |
| Q2 2022 Apr 28, 2022 | $4.01B | $3.90B | -2.65% | $5.98 | $6.11 | +2.17% | — | — |
| Q1 2022 Feb 10, 2022 | $3.92B | $4.06B | +3.55% | $5.80 | $6.77 | +16.72% | — | — |
| Q4 2021 Oct 28, 2021 | $3.60B | $4.06B | +12.73% | $4.92 | $6.82 | +38.62% | — | — |
| Q3 2021 Jul 29, 2021 | $3.84B | $3.84B | +0.00% | $5.53 | $6.13 | +10.85% | — | — |
| Q2 2021 Apr 29, 2021 | $3.93B | $4.16B | +5.92% | $7.43 | $8.79 | +18.30% | — | — |